%0 Journal Article
%T Antibiotics for MDR Pathogens
%A Gary A. Noskin
%A MD
%A Pavani Reddy
%A MD
%A Smitha Chadaga
%A MD
%J Journal of Hospital Medicine
%D 2009
%R 10.1002/jhm.505
%X Abstract The recent rise in antimicrobial resistance among health©\care associated pathogens is a growing public health concern. According to the National Nosocomial Infections Surveillance System, rates of methicillin©\resistant Staphylococcus aureus (MRSA) in intensive care units have nearly doubled over the last decade. Of equal importance, gram©\negative agents such as Pseudomonas aeruginosa, Acinetobacter baumannii, and extended©\spectrum beta lactamase¨Cproducing Enterobacteriaceae demonstrate increasing resistance to third©\generation cephalosporins, fluoroquinolones, and, in some cases, carbapenems. As a consequence, hospitalists may find themselves utilizing new antibiotics in the treatment of bacterial infections. This case©\based review will highlight 8 antibiotics that have emerging clinical indications in treating these multidrug©\resistant (MDR) pathogens. Journal of Hospital Medicine 2009;4:E8¨CE15. £¿ 2009 Society of Hospital Medicine
%U https://www.journalofhospitalmedicine.com/jhospmed/article/128380/antibiotics-mdr-pathogens